Financials

  • Market Capitalization 134.51 M
  • Employee 61
  • Founded 1996
  • CEO N/A
  • Website www.acumenpharm.com
  • Headquarter Delaware, United States
  • FIGI BBG0058YJ317
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.05
Fiyat/satışlar oranı
638.93

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3715
RNA
Atrium Therapeutics, Inc. - Common Stock
7.91 USD-3.65%-0.88%-23.72%-88.75%135.31 M USD
3730
VYGR
Voyager Therapeutics, Inc. - Common Stock
2.19 USD-3.52%-11.34%-30.91%-52.90%134.94 M USD
3734
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.56 USD-5.08%-5.08%-13.85%+35.76%136.33 M USD
3742
KRRO
Korro Bio, Inc. - Common Stock
8.69 USD-7.26%-11.05%-36.06%-77.66%127.97 M USD

Haberler